Metropolis Healthcare posts ₹450 crore in Q1FY27, profit up 27%
Ebitda for the quarter stood at Rs 113.2 crore, representing a 27.1 per cent growth YoY, while profit after tax was up 25 per cent to Rs 56.9 crore.
Your blog category
Ebitda for the quarter stood at Rs 113.2 crore, representing a 27.1 per cent growth YoY, while profit after tax was up 25 per cent to Rs 56.9 crore.
Quarterly revenue in Revvity's life sciences unit fell 3% from a year earlier to $359 million, primarily due to an expected roughly 20% decline in its Signals software business linked…
Announcing the decision, the minister said the proposed university would provide an integrated framework for education, research, clinical studies and drug development in AYUSH systems of medicine.
Imports from Asean increased by 14% to nearly Rs 13,000 crore FY25-26, led by syringes, medical gloves, dialysis products, consumables and imaging equipment, including X-ray machines, making it harder for…
An FDA investigation has linked the outbreak, which has expanded to nine states, to iceberg lettuce served at Taco Bell restaurants and sourced from privately held Taylor Farms operations in…
The health insurance joint venture of Aditya Birla Capital reported a 50% year-on-year surge in gross written premium of Rs 2,196 crore at the end of June. It also booked…
On Monday evening, the govt issued a GR directing MMC to begin registration of CCMP-BHMS practitioners, confirmed MMC registrar Dr Rakesh Waghmare.
CDSCO Approved India's first PCAB-based co-packaged H. pylori eradication 14 days blister kit pack is set to redefine treatment standards with improved efficacy, patient convenience, and adherence. Brand Connect Initiative
The figure includes expenses for medical care, public health services and lost productivity, not just for the 57 adult patients and for caregivers of the 43 infected children but also…
The MoU aims to establish a collaborative framework for interdisciplinary research, medical technology innovation, technology translation and capacity building.